Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 1
1988 1
1989 5
1990 4
1991 3
1992 8
1993 21
1994 9
1995 12
1996 7
1997 13
1998 12
1999 7
2000 10
2001 6
2002 8
2003 6
2004 10
2005 15
2006 10
2007 14
2008 12
2009 13
2010 11
2011 14
2012 13
2013 16
2014 36
2015 39
2016 50
2017 48
2018 63
2019 65
2020 63
Text availability
Article attribute
Article type
Publication date

Search Results

559 results
Results by year
Filters applied: . Clear all
Page 1
Risk stratification and medical therapy of pulmonary arterial hypertension.
Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Galiè N, et al. Eur Respir J. 2019 Jan 24;53(1):1801889. doi: 10.1183/13993003.01889-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545971 Free PMC article. Review.
Lung transplantation may be required in most advanced cases on maximal medical therapy....
Lung transplantation may be required in most advanced cases on maximal medical therapy....
Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally.
Hakim A, Cooke KR, Pavletic SZ, Khalid M, Williams KM, Hashmi SK. Hakim A, et al. Bone Marrow Transplant. 2019 Mar;54(3):383-392. doi: 10.1038/s41409-018-0266-6. Epub 2018 Jul 23. Bone Marrow Transplant. 2019. PMID: 30038355 Free article. Review.
The incidence of bronchiolitis obliterans syndrome (BOS), a devastating manifestation of chronic graft-versus-host-disease, may rise globally due to steady increases in utilization of allogeneic hematopoietic cell transplantation (HCT). ...Important elements of treatment i …
The incidence of bronchiolitis obliterans syndrome (BOS), a devastating manifestation of chronic graft-versus-host-disease, may rise globall …
Immunosuppression for Lung Transplantation: Current and Future.
Chandrashekaran S, Crow Pharm SA, Shah SZ, Arendt Pharm CJ, Kennedy CC. Chandrashekaran S, et al. Curr Transplant Rep. 2018 Sep;5(3):212-219. doi: 10.1007/s40472-018-0199-4. Epub 2018 Jul 13. Curr Transplant Rep. 2018. PMID: 30740294 Free PMC article.
RECENT FINDINGS: This review article summarizes the recent studies and developments in lung transplant immunosuppression. Novel immunosuppressive medications and strategies used in other solid organ transplantations are being trialed in lung transplantation. …
RECENT FINDINGS: This review article summarizes the recent studies and developments in lung transplant immunosuppression. Novel immun …
Updated treatment algorithm of pulmonary arterial hypertension.
Galiè N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A. Galiè N, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D60-72. doi: 10.1016/j.jacc.2013.10.031. J Am Coll Cardiol. 2013. PMID: 24355643 Free article. Review.
These are the considerable challenges faced when proposing appropriate updates to the current evidence-based treatment algorithm.The current treatment algorithm may be divided into 3 main areas: 1) general measures, supportive therapy, referral strategy, acute vasoreactivity test …
These are the considerable challenges faced when proposing appropriate updates to the current evidence-based treatment algorithm.The current …
Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management?
Tomassetti S, Ryu JH, Piciucchi S, Chilosi M, Poletti V. Tomassetti S, et al. Semin Respir Crit Care Med. 2016 Jun;37(3):378-94. doi: 10.1055/s-0036-1583176. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231862 Review.
Recent findings suggest that idiopathic NSIP is a complex clinical entity with a disease spectrum that includes at least three different phenotypes: NSIP associated with autoimmune features, emphysema, and familial interstitial lung disease. ...Oxygen therapy, pulmonary re …
Recent findings suggest that idiopathic NSIP is a complex clinical entity with a disease spectrum that includes at least three different phe …
Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management.
Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Vasakova M, et al. Am J Respir Crit Care Med. 2017 Sep 15;196(6):680-689. doi: 10.1164/rccm.201611-2201PP. Am J Respir Crit Care Med. 2017. PMID: 28598197 No abstract available.
Report from the American Society of Transplantation on frailty in solid organ transplantation.
Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, Budev M, Duarte-Rojo A, Dunn M, Hall S, Harhay MN, Johansen KL, Joseph S, Kennedy CC, Kransdorf E, Lentine KL, Lynch RJ, McAdams-DeMarco M, Nagai S, Olymbios M, Patel J, Pinney S, Schaenman J, Segev DL, Shah P, Singer LG, Singer JP, Sonnenday C, Tandon P, Tapper E, Tullius SG, Wilson M, Zamora M, Lai JC. Kobashigawa J, et al. Am J Transplant. 2019 Apr;19(4):984-994. doi: 10.1111/ajt.15198. Epub 2018 Dec 22. Am J Transplant. 2019. PMID: 30506632 Free PMC article.
A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by the American Society of Nephrology (ASN), the American Society of Transplant Surgeons (ASTS), and th …
A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Tr
Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup.
Joannidis M, Forni LG, Klein SJ, Honore PM, Kashani K, Ostermann M, Prowle J, Bagshaw SM, Cantaluppi V, Darmon M, Ding X, Fuhrmann V, Hoste E, Husain-Syed F, Lubnow M, Maggiorini M, Meersch M, Murray PT, Ricci Z, Singbartl K, Staudinger T, Welte T, Ronco C, Kellum JA. Joannidis M, et al. Intensive Care Med. 2020 Apr;46(4):654-672. doi: 10.1007/s00134-019-05869-7. Epub 2019 Dec 9. Intensive Care Med. 2020. PMID: 31820034 Free PMC article.
Furthermore, emphasis was put on patients receiving organ support (RRT, IMV and/or ECMO) and its impact on lung and kidney function. ...Recommendations for research were formulated, targeting lung-kidney interactions to improve care processes and outcomes in critica …
Furthermore, emphasis was put on patients receiving organ support (RRT, IMV and/or ECMO) and its impact on lung and kidney function. …
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).
Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J. Bolaños-Meade J, et al. Lancet Haematol. 2019 Mar;6(3):e132-e143. doi: 10.1016/S2352-3026(18)30221-7. Lancet Haematol. 2019. PMID: 30824040 Free PMC article. Clinical Trial.
BACKGROUND: Prevention of graft-versus-host disease (GvHD) without malignant relapse is the overall goal of allogeneic haemopoietic cell transplantation (HCT). ...FUNDING: US National Health, Lung, and Blood Institute; National Cancer Institute; National Institute o …
BACKGROUND: Prevention of graft-versus-host disease (GvHD) without malignant relapse is the overall goal of allogeneic haemopoietic cell …
Human airway organoid engineering as a step toward lung regeneration and disease modeling.
Tan Q, Choi KM, Sicard D, Tschumperlin DJ. Tan Q, et al. Biomaterials. 2017 Jan;113:118-132. doi: 10.1016/j.biomaterials.2016.10.046. Epub 2016 Oct 28. Biomaterials. 2017. PMID: 27815996 Free PMC article.
The development of lung tissue-like organoids from human adult-derived cells has not previously been reported. Here we combined human adult primary bronchial epithelial cells, lung fibroblasts, and lung microvascular endothelial cells in supportive 3D culture …
The development of lung tissue-like organoids from human adult-derived cells has not previously been reported. Here we combined human …
559 results
Jump to page
Feedback